Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 expression in lymphatic malignancies.

Y Soini1, P Pääkkö, M Alavaikko

  • 1Department of Pathology, University of Oulu, Finland.

Journal of Clinical Pathology
|November 1, 1992
PubMed
Summary

p53 protein expression was investigated in lymphoid tissues. Positivity in non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review.

Placenta·2022
Same author

Chloropicrin-induced toxicity in the respiratory system.

Toxicology letters·2020
Same author

Twist and Zeb1 expression identify mycosis fungoides patients with low risk of disease progression.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Quantitative estimation of mercury intake by toxicokinetic modelling based on total mercury levels in humans.

Environment international·2018
Same author

The xenoestrogens, bisphenol A and para-nonylphenol, decrease the expression of the ABCG2 transporter protein in human term placental explant cultures.

Molecular and cellular endocrinology·2016
Same author

Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system.

Placenta·2015

Area of Science:

  • Oncology
  • Molecular Pathology
  • Immunohistochemistry

Background:

  • The p53 protein is a tumor suppressor involved in cell cycle regulation and apoptosis.
  • Alterations in p53 gene expression are implicated in various cancers, including lymphomas.

Purpose of the Study:

  • To determine the expression levels of p53 protein in different types of malignant and benign lymphoid tissues.
  • To assess the potential role of p53 in the pathogenesis and progression of lymphomas.

Main Methods:

  • Immunohistochemical analysis of p53 protein expression was performed on tissue samples.
  • Studied tissues included non-Hodgkin's lymphomas (NHL), Hodgkin's lymphomas (HL), atypical hyperplasias, and benign reactive hyperplasias.

Main Results:

  • p53 protein was expressed in 31% of NHL cases, with varying proportions of positive tumor cells.
  • p53 positivity was observed in 30% of HL cases, specifically in Reed-Sternberg cells.
  • No p53 expression was detected in benign lymphoid hyperplasias or atypical hyperplasias.

Conclusions:

  • p53 positivity in lymphomas suggests a role for p53 gene mutations in their development.
  • Increased p53 expression in high-grade lymphomas indicates its involvement in disease progression.
  • p53 immunohistochemical staining may serve as a marker for distinguishing malignant from benign lymphoid lesions.

Related Experiment Videos